Published in Dig Dis Sci on September 01, 1994
Iron, anaemia, and inflammatory bowel diseases. Gut (2004) 2.03
Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol (2010) 1.56
Anemia and inflammatory bowel diseases. World J Gastroenterol (2009) 1.32
Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. World J Gastroenterol (2010) 1.06
Treatment of anemia in inflammatory bowel disease--systematic review and meta-analysis. PLoS One (2013) 0.99
Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease. Br J Nutr (2011) 0.93
Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutr Metab (Lond) (2013) 0.83
Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice. PLoS One (2013) 0.83
High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life. Blood Transfus (2016) 0.81
Stimulating erythropoiesis in inflammatory bowel disease associated anemia. World J Gastroenterol (2007) 0.81
Anemia in inflammatory bowel disease: a neglected issue with relevant effects. World J Gastroenterol (2014) 0.79
Use of agents stimulating erythropoiesis in digestive diseases. World J Gastroenterol (2009) 0.79
Maresin 1 ameliorates iron-deficient anemia in IL-10(-/-) mice with spontaneous colitis by the inhibition of hepcidin expression though the IL-6/STAT3 pathway. Am J Transl Res (2016) 0.75
A snapshot of the nutritional status of Crohn's disease among adolescents in Brazil: a prospective cross-sectional study. BMC Gastroenterol (2015) 0.75
Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease. Nutr Metab (Lond) (2013) 0.75
Dietary iron does not impact the quality of life of patients with quiescent ulcerative colitis: an observational study. Nutr J (2013) 0.75
A new iron free treatment with oral fish cartilage polysaccharide for iron deficiency chronic anemia in inflammatory bowel diseases: a pilot study. World J Gastroenterol (2007) 0.75
Estimation of optical pathlength through tissue from direct time of flight measurement. Phys Med Biol (1988) 4.63
Computer based prescribing. BMJ (1995) 3.82
An audit of doctor's management of patients with chest pain in the accident and emergency department. Q J Med (1989) 3.76
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
The road to professionalism in medical informatics: a proposal for debate. Methods Inf Med (1995) 3.54
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52
Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet (1993) 3.42
Verifying quality and safety in health informatics services. BMJ (2001) 3.31
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22
Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther (2013) 2.90
Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors. Aliment Pharmacol Ther (2012) 2.67
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet (1999) 2.29
Lymphocytic gastritis and gastric permeability in patients with celiac disease. Gastroenterology (1996) 2.26
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Aliment Pharmacol Ther (2015) 2.25
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut (2005) 2.17
Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med (1996) 2.16
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
Philosophies for the design and development of clinical decision-support systems. Methods Inf Med (1993) 2.01
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
The NHS's new information strategy. Emphasises putting information to work for patients and staff, not technology. BMJ (1998) 1.99
Evaluation of a virtual endoscopy simulator for training in gastrointestinal endoscopy. Endoscopy (2002) 1.91
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology (1998) 1.86
Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut (2005) 1.78
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
Decision aids and the law. Lancet (1989) 1.75
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
Methods of quantitating cerebral near infrared spectroscopy data. Adv Exp Med Biol (1988) 1.67
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med (1997) 1.64
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62
Trends over time in Helicobacter pylori gastritis in Kenya. Eur J Gastroenterol Hepatol (2000) 1.59
Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer (2000) 1.58
Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology (2001) 1.56
Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease. Endoscopy (1998) 1.53
Symptomatic brachial artery aneurysm in a child. J Pediatr Surg (1994) 1.53
Recent results of treatment of infantile hypertrophic pyloric stenosis. Arch Dis Child (1988) 1.51
Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Endoscopy (2006) 1.49
Retinal prosthesis: an encouraging first decade with major challenges ahead. Ophthalmology (2001) 1.48
Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab (2001) 1.47
Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies. Eur J Nucl Med (1996) 1.47
Stillbirths and neonatal encephalopathy in Kathmandu, Nepal: an estimate of the contribution of birth asphyxia to perinatal mortality in a low-income urban population. Paediatr Perinat Epidemiol (2000) 1.46
Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood (1986) 1.46
Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. Dig Liver Dis (2004) 1.45
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol (1996) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy (2009) 1.41
Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy. Gastroenterology (1997) 1.41
Construction of clinical scoring systems. BMJ (1990) 1.39
[Food-dependent Cushing syndrome of long standing with mild clinical features]. Dtsch Med Wochenschr (2000) 1.38
Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol (1997) 1.37
ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr (2006) 1.37
Back to basics on NHS networking. BMJ (2000) 1.37
Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis. Endoscopy (2003) 1.34
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther (2006) 1.33
Review article: the role of anti-TNF in the management of ulcerative colitis -- past, present and future. Aliment Pharmacol Ther (2013) 1.32
HLA antigens in inflammatory bowel disease. Gastroenterology (1982) 1.31
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol (1989) 1.30
Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol (2000) 1.26
Severe exercise hypoxaemia with normal or near normal X-rays: a feature of Pneumocystis carinii infection. Lancet (1988) 1.24
Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol (2006) 1.23
Does passage of a patency capsule indicate small-bowel patency? A prospective clinical trial? Endoscopy (2005) 1.22
Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther (2011) 1.22
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
Evaluating black-boxes as medical decision aids: issues arising from a study of neural networks. Med Inform (Lond) (1990) 1.17
Radiation doses of collimated vs non-collimated cephalometric exposures. Dentomaxillofac Radiol (2003) 1.17
Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease. Gut (2002) 1.17
Serious ocular complications associated with blowout fractures of the orbit. Am J Ophthalmol (1966) 1.17
Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control. J Clin Invest (1975) 1.16
Lipid translocation across the human erythrocyte membrane. Regulatory factors. J Biol Chem (1982) 1.15
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease. J Crohns Colitis (2012) 1.15
The safety and quality of decision support systems. Yearb Med Inform (2006) 1.12
Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol (1997) 1.12
Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med (1997) 1.12
Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci (1989) 1.11
Prevalence of malnutrition in 1760 patients at hospital admission: a controlled population study of body composition. Clin Nutr (2003) 1.10
Same information, different decisions: format counts. Format as well as content matters in clinical information. BMJ (1999) 1.10
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut (2007) 1.09
Thalidomide for treatment of severe intestinal bleeding. Gut (2004) 1.09
Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther (2004) 1.09
Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study. Ann Oncol (2002) 1.09
Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol (2007) 1.09
Cognitive maturation in preterm and term born adolescents. J Neurol Neurosurg Psychiatry (2007) 1.08
Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab (1999) 1.08
A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. J Crohns Colitis (2010) 1.08
Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res (1996) 1.08
Nutrition in the elderly. Best Pract Res Clin Gastroenterol (2001) 1.07
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood (2000) 1.06